Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05451810 |
|---|---|
| Brief Title: | A Study to Evaluate Adverse Events of Subcutaneous (SC) Epcoritamab Administered in the Outpatient Setting in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic Follicular Lymphoma |
| First Submitted : | July 6, 2022 |
| First Submitted that Met QC Criteria : | July 6, 2022 |
| First Posted : | July 11, 2022 |
| Last Update Submitted that Met QC Criteria : | May 6, 2024 |
| Last Update Posted : | May 7, 2024 |